GRX (The Gabelli Healthcare & Wellness Trust) Stock Analysis - Analyst Ratings

The Gabelli Healthcare & Wellness Trust (GRX) is a publicly traded Financial Services sector company. As of May 21, 2026, GRX trades at $8.97 with a market cap of $131.76M and a P/E ratio of 0.00. GRX moved +0.78% today. Year to date, GRX is -6.05%; over the trailing twelve months it is -6.24%. Its 52-week range spans $8.90 to $11.15. Rallies surfaces GRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate GRX?

The average price target is $0.00.

GRX Key Metrics

Key financial metrics for GRX
MetricValue
Price$8.97
Market Cap$131.76M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.17%
52-Week High$11.15
52-Week Low$8.90
Volume2
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

GRX Analyst Consensus

GRX analyst coverage data. Average price target: $0.00.

Latest GRX News

Recent GRX Insider Trades

  • GABELLI MARIO J bought 3.80K (~$36.40K) on Jan 12, 2026.
  • GABELLI MARIO J bought 1.01K (~$9.68K) on Jan 12, 2026.
  • GABELLI MARIO J bought 990 (~$9.48K) on Jan 8, 2026.

Common questions about GRX

What do analysts rate GRX?
The average price target is $0.00.
Does Rallies show GRX price targets?
Yes. Rallies tracks GRX analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is GRX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for GRX. It does not provide personalized investment advice.
GRX

GRX